Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntegraFin Holdings Regulatory News (IHP)

Share Price Information for IntegraFin Holdings (IHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 301.50
Bid: 301.00
Ask: 302.50
Change: 6.50 (2.20%)
Spread: 1.50 (0.498%)
Open: 287.50
High: 302.00
Low: 287.50
Prev. Close: 295.00
IHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Initial Admission - Official List

2 Mar 2018 07:00

RNS Number : 4633G
IntegraFin Holdings plc
02 March 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND OR SOUTH AFRICA.

For Immediate Release

2 March 2018

IntegraFin Holdings plc

Admission to the Official List and to trading on the London Stock Exchange

Further to the announcement published on 27 February 2018 in connection with the initial public offering of the Company and publication of the prospectus, IntegraFin Holdings plc ("IntegraFin" or the "Company") is pleased to announce that its entire issued share capital, comprising 331,322,014 Ordinary Shares, has today been admitted to the premium listing segment of the Official List of the Financial Conduct Authority and to trading on London Stock Exchange plc's main market for listed securities under the ticker "IHP".

Ends

Enquiries

Peel Hunt - Sponsor +44 (0)20 7418 8900

Jock Maxwell Macdonald

Indy Bhattacharyya

Guy Wiehahn

Rishi Shah

 

Evercore - Financial Adviser +44 (0)20 7653 6000

Ollie Clayton

Jim Renwick

Demetris Efthymiou

Lucy Wylde

 

Lansons +44 (0)20 7294 3691

Tony Langham

Rollo Crichton-Stuart

Maddy Morgan-Williams

Eva Murphy

Shiv Talwar

 

Important Notice

This announcement has been prepared by and is the sole responsibility of the Company.

Terms used but not defined in this announcement have the meanings given to them in the prospectus published by the Company on 27 February 2018.

Neither this announcement nor any copy of it may be taken or transmitted, published or distributed, directly or indirectly, into the United States, New Zealand, Australia, Canada, Japan or the Republic of South Africa or to any persons in any of those jurisdictions or any other jurisdiction where to do so would constitute a violation of the relevant securities laws of such jurisdiction. Any failure to comply with this restriction may constitute a violation of United States, New Zealand, Australian, Canadian, Japanese or South African securities laws. The distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

This announcement does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for any Shares or other securities in the United States, New Zealand, Australia, Canada, Japan or the Republic of South Africa or in any other jurisdiction in which such offer or solicitation is unlawful, prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction. The Offer and the distribution of this announcement and other information in connection with the Offer and Admission in certain jurisdictions may be restricted by law and persons into whose possession this announcement, any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. Neither this announcement nor any part of it nor the fact of its distribution shall form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever.

Acquiring investments to which this announcement relates may expose an investor to a significant risk of losing the entire amount invested. Persons considering making such investments should consult an authorised person specialising in advising on such investments. This announcement does not constitute a recommendation concerning the Shares. The value of Shares can decrease as well as increase. Potential investors should consult a professional adviser as to the suitability of the Shares for the person concerned. Past performance cannot be relied upon as a guide to future performance.

This announcement is not for distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), New Zealand, Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction where it is unlawful to distribute this announcement. In particular, this announcement is not an offer of securities for sale in the United States. The securities proposed to be offered have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or with any securities regulatory authority of any state or jurisdiction of the United States, and may not and will not be offered, sold, resold, pledged, delivered, distributed or transferred, directly or indirectly, in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The securities proposed to be offered will be offered and sold outside the United States in "offshore transactions" exempt from the registration requirements of the Securities Act in reliance on Regulation S, or another exemption from, or in, a transaction not subject to the registration requirements of the Securities Act.  There will be no public offer of the securities referred to herein in any jurisdiction, including in the United States, New Zealand, Australia, Canada, Japan or the Republic of South Africa. The securities referred to herein have not been registered under the applicable securities laws of New Zealand, Australia, Canada, Japan or the Republic of South Africa and, subject to certain exceptions, may not be offered or sold within New Zealand, Australia, Canada, Japan or the Republic of South Africa or to any national, resident or citizen of New Zealand, Australia, Canada, Japan or the Republic of South Africa.

This announcement is only addressed to and directed at persons in member states of the European Economic Area ("EEA") who are qualified investors within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC), as amended ("Qualified Investors"). In addition, in the United Kingdom, this announcement is addressed and directed only at Qualified Investors who (i) are persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"), (ii) are persons who are high net worth entities falling within Article 49(2)(a) to (d) of the Order, and (iii) to persons to whom it may otherwise be lawful to communicate it to (all such persons being referred to as "relevant persons"). Any investment or investment activity to which this announcement relates is available only to relevant persons in the United Kingdom and Qualified Investors in any member state of the EEA other than the United Kingdom, and will be engaged in only with such persons. Other persons should not rely or act upon this announcement or any of its contents.

Any purchase of Shares in the proposed Offer should be made solely on the basis of the information contained in the Prospectus. This announcement has not been approved by any competent regulatory authority.

Peel Hunt is authorised and regulated in the UK by the FCA and is acting exclusively for the Company, and no one else, in connection with the Offer and Admission and will not regard any other person (whether or not a recipient of this announcement) as a client in relation to the Offer and Admission and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for giving advice in relation to the Offer and Admission, the contents of this announcement or any transaction or arrangement referred to in this announcement. Peel Hunt and its affiliates may have engaged in transactions with, and provided various investment banking, financial advisory and other services to, the Company, for which it would have received customary fees. Peel Hunt and its affiliates may provide such services to the Company or members of the Group in the future.

Evercore is authorised and regulated in the UK by the FCA and is acting exclusively for the Company, and no one else, in connection with the Offer and Admission and will not regard any other person (whether or not a recipient of this announcement) as a client in relation to the Offer and Admission and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for giving advice in relation to the Offer and Admission, the contents of this announcement or any transaction or arrangement referred to in this announcement. Evercore and its affiliates may have engaged in transactions with, and provided various investment banking, financial advisory and other services to, the Company, for which it would have received customary fees. Evercore and its affiliates may provide such services to the Company or members of the Group in the future.

Apart from the responsibilities and liabilities, if any, which may be imposed on them by FSMA or the regulatory regime established thereunder, neither Peel Hunt, Evercore nor any of its or their subsidiary undertakings, affiliates or any of their respective partners, directors, officers, employees, advisers, agents or any other person accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy, completeness or fairness of the information or opinions in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company, its subsidiaries or associated companies, the Shares, the Offer or Admission whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

In connection with the Offer, Peel Hunt and any of its affiliates, acting as an investor for its or their own account(s), may purchase Shares and, in that capacity, may retain, purchase, sell, offer to sell or otherwise deal for its or their own account(s) in the Shares, any other securities of the Company or other related investments in connection with the Offer or otherwise. Accordingly, references in this announcement and the Prospectus once published to the Shares being offered, sold, purchased, acquired, placed or otherwise dealt with should be read as including any offer or sale to, or purchase, acquisition, placement or dealing by, Peel Hunt and any of its affiliates acting as an investor for its or their own account(s). Peel Hunt does not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligation to do so.

Information to Distributors

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the Shares have been subject to a product approval process, which has determined that such Shares which are the subject of the Offer are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, Distributors should note that: the price of the Shares may decline and investors could lose all or part of their investment; the Shares offer no guaranteed income and no capital protection; and an investment in the Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Offer. Furthermore, it is noted that, notwithstanding the Target Market Assessment, Peel Hunt LLP will only procure investors who meet the criteria of professional clients and eligible counterparties.

 

For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Shares.

 

Each distributor is responsible for undertaking its own target market assessment in respect of the Shares and determining appropriate distribution channels.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISFKDDNOBKDQNK
Date   Source Headline
9th May 20247:00 amRNSHolding(s) in Company
23rd Apr 20241:49 pmRNSDirector/PDMR Shareholding
16th Apr 20247:15 amRNS2nd Quarter Results
22nd Mar 20242:31 pmRNSDirector/PDMR Shareholding
12th Mar 20243:49 pmRNSHolding(s) in Company
7th Mar 20244:45 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSResult of AGM
22nd Feb 20244:21 pmRNSDirector/PDMR Shareholding
30th Jan 20249:31 amRNSDirector/PDMR Shareholding
23rd Jan 20243:27 pmRNSAnnual Report and Notice of AGM
23rd Jan 20241:24 pmRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNS1st Quarter Results
10th Jan 202412:50 pmRNSHolding(s) in Company
8th Jan 20243:33 pmRNSDirector/PDMR Shareholding
5th Jan 20244:10 pmRNSDirector/PDMR Shareholding
22nd Dec 202311:52 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSFinal Results
24th Nov 202312:26 pmRNSCFO – commencement date of appointment
22nd Nov 20233:01 pmRNSDirector/PDMR Shareholding
25th Oct 20231:10 pmRNSHolding(s) in Company
24th Oct 202311:35 amRNSDirector/PDMR Shareholding
17th Oct 202310:01 amRNSMajor Shareholding Notifications
17th Oct 20237:00 amRNS4th Quarter Results
22nd Sep 202310:33 amRNSDirector/PDMR Shareholding
23rd Aug 202312:09 pmRNSDirector/PDMR Shareholding
24th Jul 20235:47 pmRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNS3rd Quarter Results
7th Jul 20238:18 amRNSAppointment of Chief Financial Officer
3rd Jul 20232:09 pmRNSDirector/PDMR Shareholding
26th Jun 20235:34 pmRNSDirector/PDMR Shareholding
26th Jun 20232:50 pmRNSDirector/PDMR Shareholding - Replacement
22nd Jun 20232:03 pmRNSDirector/PDMR Shareholding
12th Jun 20234:41 pmRNSHolding(s) in Company
2nd Jun 20235:30 pmRNSHolding(s) in Company
2nd Jun 20235:23 pmRNSHolding(s) in Company
26th May 20237:00 amRNSHalf-year Report
23rd May 20235:25 pmRNSHolding(s) in Company
23rd May 202311:53 amRNSDirector/PDMR Shareholding
16th May 202312:25 pmRNSHolding(s) in Company
10th May 20233:26 pmRNSHolding(s) in Company
3rd May 20234:20 pmRNSHolding(s) in Company
25th Apr 202311:38 amRNSDirector/PDMR Shareholding
18th Apr 20237:00 amRNS2nd Quarter Results
28th Mar 20233:18 pmRNSDirector/PDMR Shareholding
23rd Mar 20233:32 pmRNSDirector/PDMR Shareholding
23rd Feb 20235:16 pmRNSResult of AGM
22nd Feb 202310:39 amRNSDirector/PDMR Shareholding
9th Feb 20234:16 pmRNSHolding(s) in Company
31st Jan 202311:45 amRNSDirector/PDMR Shareholding
24th Jan 20235:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.